NASDAQ:ADXS

Ayala Pharmaceuticals - ADXS Competitors

$1.50

+0.14 (+10.29%)

(As of 03/23/2023 09:00 PM ET)

Add

Compare

Today's Range: $1.30
▼
$1.50
50-Day Range: N/A
52-Week Range: $1.00
▼
$10.71

Volume: 3,300 shs
Average Volume: 7,804 shs
Market Capitalization: $2.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

ADXS vs. ATNM, AMPE, AWH, PGEN, and DYN

Should you be buying Ayala Pharmaceuticals stock or one of its competitors? The main competitors of Ayala Pharmaceuticals include Actinium Pharmaceuticals (ATNM), Ampio Pharmaceuticals (AMPE), Aspira Women's Health (AWH), Precigen (PGEN), and Dyne Therapeutics (DYN).

Ayala Pharmaceuticals vs.

Ayala Pharmaceuticals (NASDAQ:ADXS) and Actinium Pharmaceuticals (NYSE:ATNM) are both health technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, community ranking, valuation, analyst recommendations, media sentiment and institutional ownership.

: Company Net Margins Return on Equity Return on Assets
Ayala Pharmaceuticals N/A N/A N/A
Actinium Pharmaceuticals N/A N/A N/A
: Ayala Pharmaceuticals and Actinium Pharmaceuticals both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
Ayala Pharmaceuticals Outperform Votes
No Votes
Underperform Votes
1
100.00%
Actinium Pharmaceuticals Outperform Votes
No Votes
Underperform Votes
1
100.00%
: In the previous week, Ayala Pharmaceuticals' average media sentiment score of 0.00 equaled Actinium Pharmaceuticals' average media sentiment score.
Company Overall Sentiment
Ayala Pharmaceuticals Neutral
Actinium Pharmaceuticals Neutral
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ayala Pharmaceuticals N/A N/A N/A N/A N/A
Actinium Pharmaceuticals N/A N/A N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ayala Pharmaceuticals
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Actinium Pharmaceuticals
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Net Margins	Return on Equity	Return on Assets
Ayala Pharmaceuticals	N/A	N/A	N/A
Actinium Pharmaceuticals	N/A	N/A	N/A

Company	Underperform	Outperform
Ayala Pharmaceuticals	Outperform Votes No Votes	Underperform Votes 1 100.00%
Actinium Pharmaceuticals	Outperform Votes No Votes	Underperform Votes 1 100.00%

Company	Overall Sentiment
Ayala Pharmaceuticals	Neutral
Actinium Pharmaceuticals	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ayala Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
Actinium Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ayala Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Actinium Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Ayala Pharmaceuticals and Actinium Pharmaceuticals tied by winning 0 of the 0 factors compared between the two stocks.

ADXS vs. The Competition

Export to Excel

Metric	Ayala Pharmaceuticals	Pharmaceuticals: Major Industry	Health Tech Sector	NASDAQ Exchange
Market Cap	N/A	$43.52B	$26.30B	$5.89B
Dividend Yield	N/A	3.27%	3.27%	4.41%
P/E Ratio	N/A	22.84	15.88	12.46
Price / Sales	N/A	168.55	371.67	66.05
Price / Cash	N/A	N/A	N/A	102.99
Price / Book	N/A	N/A	N/A	4.95
Net Income	N/A	-$4.07M	N/A	$190.85M
7 Day Performance	N/A	1.59%	-0.98%	0.21%
1 Month Performance	N/A	-7.06%	-10.24%	-6.24%
1 Year Performance	N/A	-27.38%	N/A	-19.14%

Ayala Pharmaceuticals Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATNM Actinium Pharmaceuticals	0 of 5 stars	$9.20 +0.3%	N/A	N/A	$0.00	N/A	0.00	N/A	Upcoming Earnings Analyst Downgrade
AMPE Ampio Pharmaceuticals	0 of 5 stars	$0.23 -10.6%	N/A	N/A	$0.00	N/A	0.00	N/A	Upcoming Earnings Analyst Report
AWH Aspira Women's Health	0 of 5 stars	$0.42 -16.0%	N/A	N/A	$0.00	N/A	0.00	N/A	News Coverage
PGEN Precigen	0 of 5 stars	$0.94 -6.9%	N/A	N/A	$236.36M	$26.91M	7.81	N/A
DYN Dyne Therapeutics	0 of 5 stars	$11.18 -2.6%	N/A	N/A	$629.86M	N/A	-3.45	N/A

This page (NASDAQ:ADXS) was last updated on 3/24/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ayala Pharmaceuticals - ADXS Competitors

ADXS vs. ATNM, AMPE, AWH, PGEN, and DYN

Ayala Pharmaceuticals vs.

Summary

ADXS vs. The Competition

Ayala Pharmaceuticals Competitors List

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info